PL4111865T3 - Formulacja przeciwbakteryjna mieszaniny bakteriofagów do stosowania w zapobieganiu lub leczeniu chorób powodowanych przez Salmonella spp. - Google Patents

Formulacja przeciwbakteryjna mieszaniny bakteriofagów do stosowania w zapobieganiu lub leczeniu chorób powodowanych przez Salmonella spp.

Info

Publication number
PL4111865T3
PL4111865T3 PL21870473.2T PL21870473T PL4111865T3 PL 4111865 T3 PL4111865 T3 PL 4111865T3 PL 21870473 T PL21870473 T PL 21870473T PL 4111865 T3 PL4111865 T3 PL 4111865T3
Authority
PL
Poland
Prior art keywords
bacteriophages
preventing
mixture
diseases caused
treating diseases
Prior art date
Application number
PL21870473.2T
Other languages
English (en)
Inventor
Nicolas FERREIRA SOTO
Mauro CANAVAL ALFARO
Pablo CIFUENTES PALMA
Daniel TICHY NAVARRO
Maria Sofia ZAMUDIO CANAS
Matias AGUILERA BARRIOS
Trinidad PIZARRO BLACK
Juan SACRE RAVERA
Hans PIERINGER CASTRO
Michael PINO BARRIENTOS
Rodrigo NORAMBUENA VENEGAS
Francisca CONTRERAS VERA
Angélica ZAVALA PRATI
Original Assignee
Phagelab Chile Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phagelab Chile Spa filed Critical Phagelab Chile Spa
Publication of PL4111865T3 publication Critical patent/PL4111865T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40Viruses, e.g. bacteriophages
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00Disinfectants; Antimicrobial compounds or mixtures thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10111Myoviridae
    • C12N2795/10121Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10111Myoviridae
    • C12N2795/10132Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10311Siphoviridae
    • C12N2795/10321Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10311Siphoviridae
    • C12N2795/10332Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL21870473.2T 2021-05-19 2021-05-19 Formulacja przeciwbakteryjna mieszaniny bakteriofagów do stosowania w zapobieganiu lub leczeniu chorób powodowanych przez Salmonella spp. PL4111865T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CL2021/050044 WO2022241579A1 (es) 2021-05-19 2021-05-19 Formulación antibacteriana compuesta de una mezcla de bacteriófagos; uso y método para prevenir o tratar enfermedades causadas por salmonella spp. en animales de crianza mediante la administración oral de la formulación

Publications (1)

Publication Number Publication Date
PL4111865T3 true PL4111865T3 (pl) 2023-07-10

Family

ID=84140307

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21870473.2T PL4111865T3 (pl) 2021-05-19 2021-05-19 Formulacja przeciwbakteryjna mieszaniny bakteriofagów do stosowania w zapobieganiu lub leczeniu chorób powodowanych przez Salmonella spp.

Country Status (4)

Country Link
US (1) US11826391B2 (pl)
EP (1) EP4111865B1 (pl)
PL (1) PL4111865T3 (pl)
WO (1) WO2022241579A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024042387A1 (en) * 2022-08-22 2024-02-29 Phagelab Chile Spa Bacteriophage cocktail with broad-spectrum lytic activity against salmonella serovars
CN118834780B (zh) * 2024-06-11 2025-11-18 江苏省家禽科学研究所 一种丙酸钠抑制沙门氏菌毒力因子的方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101151516B1 (ko) 2008-12-24 2012-05-30 씨제이제일제당 (주) 신규한 박테리오파지 및 이를 포함하는 항균 조성물
EP2550870A1 (en) 2011-07-27 2013-01-30 Universitat Autònoma De Barcelona Novel salmonella bacteriophage compositions and uses thereof
JP6112961B2 (ja) 2013-05-09 2017-04-12 サラヤ株式会社 サルモネラ属菌に対して溶菌性を示す新規バクテリオファージ、及びそれを含有する組成物
US10576114B2 (en) 2015-11-25 2020-03-03 Universidad De Los Andes Composition comprising bacteriophages for reducing, eliminating and/or preventing Salmonella enteritidis, Salmonella typhimurium and Salmonella paratyphi B
CN108359644B (zh) 2018-02-07 2019-08-02 青岛诺安百特生物技术有限公司 一种宽谱沙门氏菌噬菌体及其应用

Also Published As

Publication number Publication date
US20230270801A1 (en) 2023-08-31
US11826391B2 (en) 2023-11-28
EP4111865A1 (en) 2023-01-04
EP4111865B1 (en) 2023-05-03
WO2022241579A1 (es) 2022-11-24

Similar Documents

Publication Publication Date Title
MX2020011250A (es) Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret.
PH12017500852A1 (en) Combination therapy for treatment of resistant bacterial infections
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
MX2016009251A (es) Derivados de 7-oxo-1, 6-diazabiciclo [3.2.1] octano y su uso como agentes antibacterianos.
CR20190224A (es) Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret
PH12016501577A1 (en) Monobactam organic compounds for the treatment of bacterial infections
ZA202002093B (en) Antibacterial compounds
MY209256A (en) Compounds affecting pigment production and use thereof for treatment of bacterial diseases
IL275795A (en) Medical bacteriophage preparations for the treatment of staphylococcus infection
MX2017012535A (es) Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
MY205173A (en) Use of benzenesulfonamide derivatives or a pharmaceutically acceptable salt thereof for treatment of adenoid cystic carcinoma
BR112021025732A2 (pt) Inibidores macrocíclicos de mcl-1
MX2019011908A (es) Macrociclos de peptidos anti-bacterianos y uso de los mismos.
MX2017014080A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
IL307344B2 (en) Lactavicin compounds, their preparation and use as antibacterial agents
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
MX2018001022A (es) Antibiotico aminoglucosido novedoso efectivo contra bacterias resistentes a multiples farmacos.
EP4111865A4 (en) Antibacterial formulation made of a mixture of bacteriophages, use thereof, and method for preventing or treating diseases caused by salmonella spp. in breeding animals, by orally administering the formulation
MX2017012539A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
BR112016018048A2 (pt) Método para o tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina no tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina na preparação de um medicamento para o tratamento ou prevenção de uma infecção bacteriana, método para melhorar a atividade antibacteriana de um inibidor de topoisomerase tipo ii bacteriana, método para melhorar a eficácia bactericida de um inibidor de topoisomerase tipo ii bacteriana, composição, agente antibacteriano, processo, e, composto
ZA202110692B (en) Compounds and methods of use thereof as antibacterial agents
SI4072532T1 (sl) Dozirna oblika za uporabo v zdravljenju ali preprečevanju bolezni
AR110913A1 (es) Compuesto aminoglucósido y su uso para prevenir o tratar enfermedades infecciosas
PL3694505T3 (pl) Związek i kompozycja do stosowania w leczeniu profilaktycznym i/lub terapeutycznym chorób ośrodkowego układu nerwowego charakteryzujących się spadkiem plastyczności neuronalnej, w szczególności charakteryzujących się spadkiem plastyczności synaptycznej
MX2022006180A (es) Derivados macrociclicos de sulfonilo como inhibidores de mcl-1.